For the Inventor, By the Inventor

Enter assignee name

Bern, Switzerland

Csl Behring Ag

USPTO Granted Patents = 26

CIPO Patents = 6

EPO Patents = 16

Trademarks = 15

Forward Citations = 158

Loading Chart...

Loading Chart...

43 inventors (with patents filed for the assignee):

Reinhard Franz Bolli (8 out of 17 patents)

Sylvia Miescher (6 out of 11 patents)

Werner Maeder (6 out of 6 patents)

4. Peter Lerch (6 out of 9 patents)

5. Nathan Brinkman (4 out of 7 patents)

6. Renzo Pedrussio (4 out of 4 patents)

7. Ibrahim El Menyawi (3 out of 3 patents)

8. Cédric Pierre Vonarburg (3 out of 3 patents)

9. Liane Hoefferer (3 out of 3 patents)

10. Adrian Zuercher (3 out of 10 patents)

11. Blaise Corthésy (2 out of 2 patents)

12. Marius Loetscher (2 out of 2 patents)

13. Doreen Siegemund (2 out of 2 patents)

14. Regula Styger (2 out of 3 patents)

15. Gilles Bioley (1 out of 3 patents)

26 patents: Sort by Forward Citations

1. 12396943 - Hemopexin formulations (2025-08-26),

2. 12325738 - Treatment of CIDP (2025-06-10),

3. 12194101 - Process for preparing an immunoglobulin preparation (2025-01-14),

4. 12144861 - Pharmaceutical product with increased stability comprising immunoglobulins (2024-11-19),

5. 11471617 - Nebultzation of immunoglobulin (2022-10-18),

6. 11419936 - Immunoglobulin preparation and storage system for an immunoglobulin preparation (2022-08-23),

7. 11312746 - Method and system of protein extraction (2022-04-26),

8. 10918696 - Methods of treatment using hemopexin compositions (2021-02-16),

9. 10829542 - Methods for affectinginfections (2020-11-10),

10. 10434176 - Immunoglobulin preparation and storage system for an immunoglobulin preparation (2019-10-08),

11. 10221233 - Compositions comprising secretory-like immunoglobulins (2019-03-05),

12. 10144774 - Method for purifying IgG (2018-12-04),

13. 10137197 - Process for preparing an immunoglobulin preparation (2018-11-27),

14. 9937229 - Methods of treatment using hemopexin compositions (2018-04-10),

15. 9932392 - Prevention of infection (2018-04-03),

CSL Behring AG is a global leader in the plasma protein biotherapeutics industry. The company specializes in the research, development, and manufacturing of life-saving and life-enhancing therapies derived from human plasma. CSL Behring focuses on treating rare and serious medical conditions, such as hemophilia, immune deficiencies, and genetic pulmonary disorders. With a commitment to innovation, quality, and patient care, CSL Behring strives to improve the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

26 Patents

#7 in Bern

#475 in Switzerland

#24,071 in the World

Bern, Switzerland

Csl Behring Ag

Forward Citations = 158

43 inventors:

Reinhard Franz Bolli (8 out of 17 patents)

Sylvia Miescher (6 out of 11 patents)

Werner Maeder (6 out of 6 patents)

4. Peter Lerch (6 out of 9 patents)

5. Nathan Brinkman (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…